Articles, Insights, & News
Vivariant Applies for Licensed Dealer (LD) Permit for Psilcybin
Toronto, December 22nd, 2021 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is proud to announce it has submitted an application for a Licensed Dealer (LD) permit to possess…
Selling Natural Health Products or Dietary Supplements on Amazon?
Selling Natural Health Products or Dietary Supplements on Amazon? In December of 2020, Amazon implemented rigorous quality specifications for Dietary Supplements and Natural Health Products sold on its platform. Among…
Vivariant Laboratories receives Analytical Testing license under the Cannabis Act.
Toronto, August 23rd, 2019 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has received its Analytical Testing license under the Cannabis Act and Cannabis…
Vivariant Receives Containment Level II Pathogen and Toxin License
Toronto, January 4, 2019 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has received its Containment Level II Pathogen and Toxin License from the…
Vivariant Laboratories Submits Cannabis Act Analytical Testing License Application
Toronto, September 16, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of it’s Analytical Testing license application in Health Canada’s new Cannabis…
Vivariant Laboratories Inc. Submits Licensed Dealer (LD) Application to Health Canada
Toronto, May 29, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of an application for a Licensed Dealer (LD) Permit to Health…
Health Canada Announces Proposed Approach to the Regulation of Cannabis
The Government of Canada has indicated that it intends to bring the proposed Cannabis Act into force no later than July 2018, subject to the approval of Parliament and Royal…